LRB operates in a niche domain of NGS data analysis
Leucine Rich Bio (LRB) has announced an alliance partnership with NextGen Life sciences for promoting its products and services.
According to the MoU signed between LRB and NextGen Life sciences, NextGen Life Sciences would provide its market depth and field penetration to promote LRB's products and services.
Speaking on this occasion, Dr Debojyoti Dhar, director (Business development and Innovation), LRB said, "Getting NextGen Life sciences on board our journey at this stage is very important for LRB and we feel that our two companies can complement each other well and we look forward to a mutually rewarding association".
"Our rich experience in the Indian lifesciences market makes us confident that NextGen Life Sciences will successfully integrate LRB products and services in India and will be growing business further together. With the addition of LRB, we are in an even stronger position to help our customers to achieve their goals for innovation and productivity. Our combine offerings will provide cutting edge technologies to accelerate Life Sciences Research and improve human health," said Dr Nagma Abbasi, MD, NextGen Life Sciences.
LRB operates in a niche domain of NGS data analysis and is involved in providing ‘software as a service' utilizing its proprietary in-house developed Human Genome Analysis, Interpretation and Reporting platform called AGIS (Advanced Genome Interpretation Suite).